𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Iron chelation therapy in myelodysplastic syndromes: evidence-based rationale and comparison of guidelines

✍ Scribed by Michael Pfeilstöcker

Book ID
107636722
Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
202 KB
Volume
3
Category
Article
ISSN
1865-5041

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predicted costs of iron-chelators in mye
Predicted costs of iron-chelators in myelodysplastic syndromes: A 10-year analysis based on actual prevalence and red cell transfusion rates
✍ Senthilkumar Durairaj; Stephen Chew; Ann Hyslop; Norene Keenan; Michael J. Grove 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 3 views

## Abstract Consideration of iron‐chelation (IC) in transfusion‐dependent patients is recommended in most clinical‐practice guidelines on myelodysplastic syndromes (MDS). The financial impact of IC on health‐care systems is predicted through economic modeling, but an analysis based on actual preval